Zydus Lifesciences Ltd (ZYDUSLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 290229, "name": "Zydus Lifesci.", "stock_name": "Zydus Lifesci.", "full_name": "Zydus Lifesciences Ltd", "name_url": "stocks-analysis/zydus-lifesci", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,119.00", "chg": 4.8, "chgp": "0.43%", "dir": 1, "prev_price": "1,114.20", "mcapval": "111,247.00 Cr", "mcap": "Mid Cap", "scripcode": 532321, "symbol": "ZYDUSLIFE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE010B01027", "curr_date": "Aug 10, 03:30 PM", "curr_time": "04:35 AM", "last_traded_at": "Aug 10, 03:30 PM IST", "bse_nse_vol": "9.85 lacs", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MS", "url": "https://www.marketsmojo.com/mojostocks#!#top10", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4144526", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ZydusLifescienc_technicaldot_4144526.png", "date": "2026-08-10 08:01:04", "description": "Zydus Lifesciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by positive signals from key technical indicators such as MACD, moving averages, and the KST oscillator, suggesting an improving price momentum that could attract renewed investor interest in the pharmaceuticals and biotechnology sector." }, { "title": "Zydus Lifesciences Ltd Falls 1.00%: Mixed Technical Signals Temper Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-falls-100-mixed-technical-signals-temper-momentum-4143894", "imagepath": "", "date": "2026-08-09 10:02:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock opens at Rs.1,116.25, down 0.91%</p>\n <p><strong>4 Aug:</strong> Slight recovery to Rs.1,118.50 (+0.20%)</p>\n <p><strong>6 Aug:</strong> Downgrade to 'Buy' by MarketsMOJO; technical momentum shifts</p>\n <p><strong>7 Aug:</strong> Week closes at Rs.1,115.20 (+0.81%) but below week open</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,126.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,115.20</div><d..." }, { "title": "Zydus Lifesciences Ltd Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-4139341", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ZydusLifescienc_mojoScore_4139341.png", "date": "2026-08-06 08:17:14", "description": "Zydus Lifesciences Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Strong Buy to Buy as of 5 August 2026. This adjustment reflects a nuanced shift in the company’s technical indicators and financial trends, despite its solid long-term fundamentals and market-beating returns." }, { "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-mixed-signals-4139047", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ZydusLifescienc_technicaldot_4139047.png", "date": "2026-08-06 08:01:11", "description": "Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in daily price, the stock’s long-term indicators remain largely positive, reflecting a complex interplay of momentum and trend signals that investors should carefully consider." }, { "title": "Zydus Lifesciences Gains 1.59%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-gains-159-4-key-factors-driving-the-weeks-momentum-4132158", "imagepath": "", "date": "2026-08-02 10:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock opens at ₹1,108.00 with minor decline amid Sensex rally</p>\n <p><strong>28 Jul:</strong> Technical momentum signals bullish outlook despite slight price dip</p>\n <p><strong>29 Jul:</strong> Mixed technical signals as stock dips 0.76%, MarketsMOJO downgrades rating</p>\n <p><strong>30 Jul:</strong> Upgraded to Strong Buy; stock rallies 2.07% nearing 52-week high</p>\n <p><strong>31 Jul:</strong> Stock closes week at ₹1,126.50, up 0.99% on strong volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">W..." }, { "title": "Zydus Lifesciences Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-upgraded-to-strong-buy-on-robust-fundamentals-and-technicals-4128041", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZydusLifescienc_mojoScore_4128041.png", "date": "2026-07-30 08:11:47", "description": "Zydus Lifesciences Ltd has been upgraded from a Buy to a Strong Buy rating by MarketsMojo as of 29 Jul 2026, reflecting significant improvements in its technical outlook alongside steady fundamental performance. The mid-cap pharmaceutical company’s Mojo Score has risen to 80.0, signalling enhanced investor confidence amid a backdrop of healthy long-term growth and attractive valuation metrics." }, { "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4127789", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZydusLifescienc_technicaldot_4127789.png", "date": "2026-07-30 08:00:30", "description": "Zydus Lifesciences Ltd has demonstrated a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is supported by a confluence of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an improving price momentum and a favourable outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-mixed-signals-4124988", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZydusLifescienc_technicaldot_4124988.png", "date": "2026-07-29 08:01:04", "description": "Zydus Lifesciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, the stock continues to demonstrate resilience with mixed signals across key technical indicators such as MACD, RSI, and moving averages, reflecting a complex interplay of market forces within the Pharmaceuticals & Biotechnology sector." }, { "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4123200", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZydusLifescienc_technicaldot_4123200.png", "date": "2026-07-28 08:01:11", "description": "Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underpinned by positive signals from key technical indicators such as the MACD and moving averages, suggesting a strengthening price momentum despite a marginal dip in the latest trading session." } ], "total": 730, "sid": "290229", "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229" }, "announcements": [ { "details": "Cadila Healthcare Limited has informed the Exchange regarding Disclosure of Consolidated Related Party Transactions for the half year ended on September 30, 2019.", "source": "NSE", "caption": "Cadila Healthcare Limited - Other General Purpose", "datetime": "09-Dec-2019" }, { "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 05, 2019, titled \"Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI\".", "source": "NSE", "caption": "Cadila Healthcare Limited - Press Release", "datetime": "05-Dec-2019" }, { "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets\".", "source": "NSE", "caption": "Cadila Healthcare Limited - Press Release", "datetime": "03-Dec-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(11 Aug 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Zydus Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 24 Jul 26", "dt": "2026-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15", "dt": "2015-10-06", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10", "dt": "2010-04-05", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: Stock opens at ₹1,108.00 with minor decline amid Sensex rally

28 Jul: Technical momentum signals bullish outlook despite slight price dip

29 Jul: Mixed technical signals as stock dips 0.76%, MarketsMOJO downgrades rating

30 Jul: Upgraded to Strong Buy; stock rallies 2.07% nearing 52-week high

31 Jul: Stock closes week at ₹1,126.50, up 0.99% on strong volume

W...

Read full news article

Zydus Lifesciences Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals

2026-07-30 08:11:47

Zydus Lifesciences Ltd has been upgraded from a Buy to a Strong Buy rating by MarketsMojo as of 29 Jul 2026, reflecting significant improvements in its technical outlook alongside steady fundamental performance. The mid-cap pharmaceutical company’s Mojo Score has risen to 80.0, signalling enhanced investor confidence amid a backdrop of healthy long-term growth and attractive valuation metrics.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-30 08:00:30

Zydus Lifesciences Ltd has demonstrated a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is supported by a confluence of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an improving price momentum and a favourable outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Signals

2026-07-29 08:01:04

Zydus Lifesciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, the stock continues to demonstrate resilience with mixed signals across key technical indicators such as MACD, RSI, and moving averages, reflecting a complex interplay of market forces within the Pharmaceuticals & Biotechnology sector.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-28 08:01:11

Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underpinned by positive signals from key technical indicators such as the MACD and moving averages, suggesting a strengthening price momentum despite a marginal dip in the latest trading session.

Read full news article